Announcements Trials

Browse Landscape

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Carcinoma, Non-Small-Cell Lung 4 Hodgkin Disease 3 Triple Negative Breast Neoplasms 2 Rhabdomyosarcoma 2 Recurrence 2 Neoplasms 2 Advanced Breast Cancer 2 Neoplasm Metastasis 1 NSCLC 1 Metastatic HER2-positive Breast Cancer 1 Lung Neoplasms 1 HER2-positive Advanced Breast Cancer 1 HER2-negative Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Adenocarcinoma 1

Interventions

pyrotinib 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HER2-positive Advanced Breast Cancer × Vinorelbine × Clear all

NCT05856383 2023-05-12

HER2-VIP

Zhejiang Cancer Hospital

HER2-positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡